New Content  edit
Get The App!

Free, Certified, On-Demand Lectures

IMPACT Live offers a series of breakfast/dinner grand rounds, visiting professorships and virtual lectures led by renowned faculty. Content is focused on hot topics in specific disease areas and novel approaches to achieving better outcomes for patients.

Certified events use outcomes-based, mobile-friendly platform to create a closed-loop learning experience, with pre-work programs and post-work quizzes to ensure lecture attendees retain concepts taught.

Free, Certified, On-Demand Lectures

IMPACT Live offers a series of breakfast/dinner grand rounds, visiting professorships and virtual lectures led by renowned faculty. Content is focused on hot topics in specific disease areas and novel approaches to achieving better outcomes for patients.

Certified events utilize our outcomes-based, mobile learning platform to create a closed-loop learning experience by providing pre-work programs and post-work quizzes to ensure attendees of the lectures retain concepts taught.



Available Topics


Maximizing PH Care Using Risk Assessment to Improve Outcomes

Learning Objectives
  • Discuss the importance of periodic risk assessment for PAH
  • Debate the expansion of risk stratification in PAH from 3 to 4 levels
  • Review the goals of PAH therapy and the potential application of triple combination therapy to achieve low-risk status in the PAH patient
  • Discuss the balance between more advanced and aggressive therapeutic approaches and the trade-off of greater side effects
  • Evaluate the criteria for referring advanced PAH patients for lung transplantation when even advanced therapeutic strategies fail to progress the patient towards low-risk status

Underserved PAH Populations: Why Don’t We Connect?

Learning Objectives
  • Define the underserved PAH population and the socioeconomic determinants of care and access to care
  • Examine the use of remote monitoring and patient evaluation technologies and strategies
  • Discuss potential solutions to maintaining access of PAH patients to specialty care
  • Discuss barriers to PAH patient identification and care that reside within current health care systems

Sleuthing Unexplained Dyspnea: Diagnostic Tools


Learning Objectives
  • Review the potential causes of unexplained dyspnea and the implications of delayed diagnosis of underlying causes as they pertain to pulmonary hypertension
  • Discuss collaborative diagnostic roles of the community physician and the PH specialty center in determining the potential presence of pulmonary hypertension and the need for expedient referral to the specialty centeric work-up
  • Compare and contrast the diagnostic tools available to determine the presence, cause and severity of pulmonary hypertension and newer diagnostic modalities that are influencing the diagnostic process
  • Review the necessary diagnostic values and implications needed to create an “index of suspicion” that pulmonary hypertension is at the core of a patient’s unexplained dyspnea

Addressing PH Subtypes: Raising Awareness of Understudied Populations


Learning Objectives
  • Review characteristics of PH patient groups that fall outside of the idiopathic category
  • Discuss the screening, diagnosis, and expedient referral of non-idiopathic patients to PH specialty centers from community generalists and specialty healthcare providers
  • Focus on understudied PH groups that require special diagnostic attention by all healthcare providers
  • Review treatment and management approaches to understudied PH patients

 

CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.
If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.
|
Speaker:
Topic:
Format:
Date:
Time:
Location:
Accreditation:



Accreditation Information


Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Global Learning Collaborative (GLC) designates each activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Learning Collaborative (GLC) designates each activity for 1.0 hour of Nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Each curriculum has been approved for 1.0 contact hour 0.1 CEUs by Global Learning Collaborative (GLC). GLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  • Maximizing PH Care Using Risk Assessment to Improve Outcomes: The Universal Activity Number for this program is JA0006235-9999-22-025-L01-P; Knowledge
  • Underserved PAH Populations: Why Don’t We Connect?:The Universal Activity Number for this program is JA0006235-0000-22-026-L01-P; 1.0 contact hour; Knowledge
  • Sleuthing Unexplained Dyspnea: Diagnostic Tools: The Universal Activity Number for this program is JA0006235-0000-22-027-L01-P; Knowledge
  • Addressing PH Subtypes: Raising Awareness of Understudied Populations: The Universal Activity Number for this program is JA0006235-0000-22-028-L01-P; Knowledge
Each learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and TotalCME, Inc. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.

Target Audience
These activities have been designed to meet the educational needs of physicians, registered nurses, and other healthcare professionals involved in the care of patients with pulmonary hypertension.

Fee Information
There is no fee for these educational activities.

A statement of credit will be issued only upon completion of the activity evaluation form and will be emailed directly to completers.



IMPACT PH Steering Committee


Program Chairs:

Richard Channick, MD
Saul Brandman Endowed Chair in PAH
Co-Director, Pulmonary Vascular Disease Program
Director, Acute and Chronic Thromboembolic Disease Program
Professor of Medicine
Pulmonary and Critical Care Division
David Geffen School of Medicine at UCLA
Los Angeles, CA



Vallerie McLaughlin, MD
Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Associate Chief of Cardiovascular Medicine
Dept. of Internal Medicine/ Cardiovascular Medicine
University of Michigan
Ann Arbor, MI


Jean Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
Division of Pulmonary, Critical Care and Sleep Medicine
University of Cincinnati
Cincinnati, OH

Martha Kingman, FNP-C, DNP
Doctor of Nursing Practice
Nurse Practitioner
Pulmonary Hypertension Program
University of Texas Southwestern Medical Center
Dallas, TX

Richard Krasuski, MD
Professor of Medicine and Pediatrics
Director, Adult Congenital Heart Disease Center
Director, Hemodynamic Research
Director, Interventional CTEPH Program
Duke University Medical Center
Durham, NC

Ioana Preston, MD
Associate Professor of Medicine
Tufts University School of Medicine
Director, Pulmonary Hypertension Center
Pulmonary, Critical Care and Sleep Division
Tufts Medical Center
Boston, MA

Sudarshan Rajagopal, MD, PhD
Associate Professor of Medicine
Co-Director, Pulmonary Vascular Disease Center
Duke University School of Medicine
Durham, NC

Rajan Saggar, MD
Professor of Medicine
Director Pulmonary Hypertension Program
Co-Director Pulmonary Vascular Disease Program
Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs
David Geffen School of Medicine, UCLA
Los Angeles, CA

Oksana A. Shlobin, MD
Medical Director, Pulmonary Hypertension Program
Inova Fairfax Hospital
Associate Professor, University of Virginia School of Medicine
Associate Professor, Georgetown University School of Medicine
Falls Church, VA



IMPACT PH Faculty

Charles Burger, MD
Professor of Medicine
Medical Director, Pulmonary Vascular Center
Pulmonary, Allergy, and Sleep Medicine
Mayo Clinic
Jacksonville, FL

Murali Chakinala, MD
Professor of Medicine
Director, Pulmonary Hypertension Center
Co-Director, Hereditary Hemorrhagic Telangiectasia Center
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine
Barnes-Jewish Hospital
St. Louis, MO

Richard Channick, MD
Saul Brandman Endowed Chair in Pulmonary Arterial Hypertension
Co-Director, Pulmonary Vascular Disease Program
Director, Acute and Chronic Thromboembolic Disease Program
Professor of Medicine
Pulmonary and Critical Care Division
David Geffen School of Medicine at UCLA
Los Angeles, CA

Curt J. Daniels, MD, FACC
Professor, Internal Medicine & Pediatrics
Dottie Dohan Shepard Endowed Professor Cardiovascular Medicine
Director, COACH Program: Columbus Ohio Adult Congenital Heart Disease Program
Director, Schooler Family Adult Congenital Heart Disease Fellowship Program The Ohio State University Medical Center
Nationwide Children's Hospital
Columbus, OH

Teresa De Marco, MD, FACC, FHFSA
Professor of Medicine and Surgery
R.H. and Jane G. Logan Endowed Chair in Cardiology
Medical Director, Heart Transplantation
PHA Scientific Leadership Council, PHCC Oversight Committee
University of California, San Francisco
San Francisco, CA

Jean Elwing, MD
Professor of Medicine
Director, Pulmonary Hypertension Program
Division of Pulmonary, Critical Care and Sleep Medicine
University of Cincinnati
Cincinnati, OH

M. Patricia George, MD
Associate Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO

Nicholas S. Hill, MD
Professor of Medicine
Tufts University School of Medicine
Chief, Division of Pulmonary & Critical Care and Sleep Medicine
Tufts Medical Center
Boston, MA

Martha Kingman, FNP-C, DNP
Doctor of Nursing Practice
Nurse Practitioner
Pulmonary Hypertension Program
University of Texas Southwestern Medical Center
Dallas, TX

Richard Krasuski, MD
Professor of Medicine and Pediatrics
Director, Adult Congenital Heart Disease Center
Director, Hemodynamic Research
Director, Interventional CTEPH Program
Duke University Medical Center
Durham, NC

Sandra Lombardi, RN
Pulmonary Hypertension Coordinator
Division of Pulmonary Vascular Medicine
University of California, San Diego
San Diego, CA

J. Wesley McConnell, MD
Medical Director, Norton Healthcare Pulmonary Hypertension Program
Pulmonologist, Norton Pulmonary Specialists
Adjunct Professor and Medical Director
Pulmonary Transplant Program
University of Kentucky
Louisville, KY

Susanne McDevitt, DNP, ACNP-BC
Nurse Practitioner
Pulmonary Hypertension Program / Division of Cardiovascular Medicine
Michigan Medicine
Ann Arbor, MI

Vallerie V. McLaughlin, MD
Associate Chief Clinical Officer, Cardiovascular Services
Director, Pulmonary Hypertension Program
University of Michigan
Ann Arbor, MI

Lana Melendres-Groves, MD
Vice Chair Diversity, Equity, and Inclusion Dept of Medicine
Medical Director, Clinical Trial Unit, DoIM
Medical Director, Pulmonary Hypertension Program
Associate Professor Dept of Internal Medicine
Pulmonary & Critical Care Division
University of New Mexico
Albuquerque, NM

Omar Minai, MD
Clinical (Adjunct) Associate Professor of Medicine
Liberty University COM
Staff Pulmonologist
Pulmonary & Critical Care Associates of the Tri-cities
Southside Regional Medical Center
Petersburg, VA

Harold Palevsky, MD
Professor of Medicine
Perelman School of Medicine of the University of Pennsylvania
Chief, Pulmonary, Allergy and Critical Care
Director, Pulmonary Vascular Disease Program
Penn Presbyterian Medical Center
Philadelphia, PA

Ioana Preston, MD
Associate Professor of Medicine,
Tufts University School of Medicine
Director, Pulmonary Hypertension Center
Director, Pulmonary Function Test Lab
Pulmonary, Critical Care and Sleep Division
Tufts Medical Center
Boston, MA

Sudarshan Rajagopal, MD, PhD
Associate Professor of Medicine
Co-Director, Pulmonary Vascular Disease Center
Duke University School of Medicine
Durham, NC

Zeenat Safdar, MD, MS, FACP, FCCP, ATSF
Professor of Medicine
Interim Director, HM Lung Center
Director, Pulmonary Hypertension Care Center and Clinical Research
Houston Methodist Hospital, Weill Cornell College of Medicine
Houston, TX

Jeffrey S. Sager, MD, MSc, FACP, FCCP
Director, Cottage Pulmonary Hypertension Center
Santa Barbara, CA

Rajan Saggar, MD
Professor of Medicine
Director Pulmonary Hypertension Program
Co-Director Pulmonary Vascular Disease Program
Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs
David Geffen School of Medicine, UCLA
Los Angeles, CA

Robert Schilz, DO, PhD
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Director, Pulmonary Vascular Disease and Lung Transplantation
University Hospitals Cleveland Medical Center
Cleveland, OH

Oksana A. Shlobin, MD
Medical Director, Pulmonary Hypertension Program
Inova Fairfax Hospital
Associate Professor, University of Virginia School of Medicine
Associate Professor, Georgetown University School of Medicine
Falls Church, VA

Traci Stewart, RN, MSN, CHFN
Nurse Clinician Specialist
Pulmonary Hypertension/Cardiomyopathy
UI Heart and Vascular Center
Iowa City, IA

Roxana Sulica, MD
Associate Professor of Medicine
Director, NYU Langone Pulmonary Hypertension Program
Division Pulmonary, Critical Care and Sleep Medicine
NYU Grossman School of Medicine
New York, NY

Victor Test, MD, FCCP
Professor of Medicine
Division Chief, Pulmonary and Critical Care Medicine
Texas Tech University Medical School
Lubbock, TX

Fernando Torres, MD
Professor of Medicine
Division of Pulmonary/ Critical Care Medicine
University of Texas Southwestern Medical Center
Head of Lung Transplant and Pulmonary Hypertension Program
William Clements University Hospital
Dallas, TX

Anjali Vaidya, MD, FACC, FASE, FACP
Professor of Medicine
Co-Director, Pulmonary Hypertension, Right Heart Failure, and CTEPH Program
Advanced Heart Failure & Cardiac Transplant
Associate Program Director, Cardiology Fellowship
Assistant Program Director, Internal Medicine Residency
Temple University Lewis Katz School of Medicine
Philadelphia, PA

Melisa Wilson, DND, APRN, ACNP, BC
AdventHealth Orlando
Doctor of Nursing Practice
Clinical Director, Advanced Lung Disease Institute
Pulmonary Hypertension Coordinator | Advanced Lung Disease @ Orlando
Central Florida
Orlando, FL



Available Formats

IMPACT Live PH events are available as a webinar and as an onsite event.

Please check the scheduled lectures tab to register for upcoming events.


If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.

Pre-work Program/ Post-work Quiz

Live events utilize a closed-loop learning experience by providing pre-work programs and post-work quizzes to accompany the lecture events to ensure attendees of the lectures retain concepts taught. The flipped classroom pre-work episodes are developed specifically to introduce key information which may be applied during the live event and encourage engagement between the attendee and faculty. Pre-work is presented by expert faculty in several short, educational episodes. Post-work quizzes allow attendees to revisit topics for a better long-term retention and test their knowledge on concepts taught at the lecture.

Compliance with Sunshine Act

The National Physician Payment Transparency Program (Sunshine Act) is a section of the Patient Protection and Affordable Care Act of 2010 that requires pharmaceutical and medical device companies to report to the Federal government certain payments (e.g. meals and other meeting expenses) they make to physicians and teaching hospitals. IMPACT PH programs fully comply with the Sunshine Act and, as a result, payments may be reportable based upon these requirements. For detailed information, please visit:

www.cms.gov

.

Jointly provided by Global Learning Collaborative (GLC) and TotalCME, Inc.

These activities are supported by educational grants from Actelion Pharmaceuticals US, Division of Janssen Pharmaceuticals and United Therapeutics Corporation.